Selected research
Market Structure
Global Vonoprazan Fumarate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Vonoprazan Fumarate Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Vonoprazan Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Vonoprazan Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Vonoprazan Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Vonoprazan Fumarate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Vonoprazan Fumarate Tablets include Sichuan Kelun Pharmaceutical, Sichuan Haihui Pharmaceutical, Shandong New Era Pharmaceutical and Takeda Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Vonoprazan Fumarate Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Vonoprazan Fumarate Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Vonoprazan Fumarate Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vonoprazan Fumarate Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Vonoprazan Fumarate Tablets Segment by Company
Sichuan Kelun Pharmaceutical
Sichuan Haihui Pharmaceutical
Shandong New Era Pharmaceutical
Takeda Pharmaceutical
Vonoprazan Fumarate Tablets Segment by Type
10mg
20mg
Vonoprazan Fumarate Tablets Segment by Application
Hospital Pharmacy
Retail Pharmacy
Vonoprazan Fumarate Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vonoprazan Fumarate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vonoprazan Fumarate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vonoprazan Fumarate Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Vonoprazan Fumarate Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vonoprazan Fumarate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vonoprazan Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Vonoprazan Fumarate Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg
- 20mg
Applications
- Hospital Pharmacy
- Retail Pharmacy
Companies covered
- Sichuan Kelun Pharmaceutical
- Sichuan Haihui Pharmaceutical
- Shandong New Era Pharmaceutical
- Takeda Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Vonoprazan Fumarate Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Vonoprazan Fumarate Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Vonoprazan Fumarate Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Vonoprazan Fumarate Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Vonoprazan Fumarate Tablets Market Dynamics
- 2.1 Vonoprazan Fumarate Tablets Industry Trends
- 2.2 Vonoprazan Fumarate Tablets Industry Drivers
- 2.3 Vonoprazan Fumarate Tablets Industry Opportunities and Challenges
- 2.4 Vonoprazan Fumarate Tablets Industry Restraints
3 Vonoprazan Fumarate Tablets Market by Manufacturers
- 3.1 Global Vonoprazan Fumarate Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Vonoprazan Fumarate Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Vonoprazan Fumarate Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Vonoprazan Fumarate Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Vonoprazan Fumarate Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Vonoprazan Fumarate Tablets Manufacturers, Product Type & Application
- 3.7 Global Vonoprazan Fumarate Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Vonoprazan Fumarate Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Vonoprazan Fumarate Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Vonoprazan Fumarate Tablets Tier 1, Tier 2, and Tier 3
4 Vonoprazan Fumarate Tablets Market by Type
- 4.1 Vonoprazan Fumarate Tablets Type Introduction
- 4.1.1 10mg
- 4.1.2 20mg
- 4.2 Global Vonoprazan Fumarate Tablets Sales by Type
- 4.2.1 Global Vonoprazan Fumarate Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Vonoprazan Fumarate Tablets Sales by Type (2021-2032)
- 4.2.3 Global Vonoprazan Fumarate Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Vonoprazan Fumarate Tablets Revenue by Type
- 4.3.1 Global Vonoprazan Fumarate Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Vonoprazan Fumarate Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Vonoprazan Fumarate Tablets Revenue Market Share by Type (2021-2032)
5 Vonoprazan Fumarate Tablets Market by Application
- 5.1 Vonoprazan Fumarate Tablets Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Retail Pharmacy
- 5.2 Global Vonoprazan Fumarate Tablets Sales by Application
- 5.2.1 Global Vonoprazan Fumarate Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Vonoprazan Fumarate Tablets Sales by Application (2021-2032)
- 5.2.3 Global Vonoprazan Fumarate Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Vonoprazan Fumarate Tablets Revenue by Application
- 5.3.1 Global Vonoprazan Fumarate Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Vonoprazan Fumarate Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Vonoprazan Fumarate Tablets Revenue Market Share by Application (2021-2032)
6 Global Vonoprazan Fumarate Tablets Sales by Region
- 6.1 Global Vonoprazan Fumarate Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Vonoprazan Fumarate Tablets Sales by Region (2021-2032)
- 6.2.1 Global Vonoprazan Fumarate Tablets Sales by Region (2021-2026)
- 6.2.2 Global Vonoprazan Fumarate Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Vonoprazan Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Vonoprazan Fumarate Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Vonoprazan Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Vonoprazan Fumarate Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Vonoprazan Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Vonoprazan Fumarate Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Vonoprazan Fumarate Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Vonoprazan Fumarate Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Vonoprazan Fumarate Tablets Revenue by Region
- 7.1 Global Vonoprazan Fumarate Tablets Revenue by Region
- 7.1.1 Global Vonoprazan Fumarate Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Vonoprazan Fumarate Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Vonoprazan Fumarate Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Vonoprazan Fumarate Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Vonoprazan Fumarate Tablets Revenue (2021-2032)
- 7.2.2 North America Vonoprazan Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Vonoprazan Fumarate Tablets Revenue (2021-2032)
- 7.3.2 Europe Vonoprazan Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Vonoprazan Fumarate Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Vonoprazan Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Vonoprazan Fumarate Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Vonoprazan Fumarate Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sichuan Kelun Pharmaceutical
- 8.1.1 Sichuan Kelun Pharmaceutical Company Information
- 8.1.2 Sichuan Kelun Pharmaceutical Business Overview
- 8.1.3 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sichuan Kelun Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
- 8.1.5 Sichuan Kelun Pharmaceutical Recent Developments
- 8.2 Sichuan Haihui Pharmaceutical
- 8.2.1 Sichuan Haihui Pharmaceutical Company Information
- 8.2.2 Sichuan Haihui Pharmaceutical Business Overview
- 8.2.3 Sichuan Haihui Pharmaceutical Vonoprazan Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sichuan Haihui Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
- 8.2.5 Sichuan Haihui Pharmaceutical Recent Developments
- 8.3 Shandong New Era Pharmaceutical
- 8.3.1 Shandong New Era Pharmaceutical Company Information
- 8.3.2 Shandong New Era Pharmaceutical Business Overview
- 8.3.3 Shandong New Era Pharmaceutical Vonoprazan Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shandong New Era Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
- 8.3.5 Shandong New Era Pharmaceutical Recent Developments
- 8.4 Takeda Pharmaceutical
- 8.4.1 Takeda Pharmaceutical Company Information
- 8.4.2 Takeda Pharmaceutical Business Overview
- 8.4.3 Takeda Pharmaceutical Vonoprazan Fumarate Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Takeda Pharmaceutical Vonoprazan Fumarate Tablets Product Portfolio
- 8.4.5 Takeda Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Vonoprazan Fumarate Tablets Value Chain Analysis
- 9.1.1 Vonoprazan Fumarate Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Vonoprazan Fumarate Tablets Production Mode & Process
- 9.2 Vonoprazan Fumarate Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Vonoprazan Fumarate Tablets Distributors
- 9.2.3 Vonoprazan Fumarate Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst